Align Technology has grown revenue 3.5% a year over three years and 3.6% a year over five, with earnings per share compounding at 12%. Revenue growth, 3-year annual rate: +3.5% (Medical Instruments & Supplies median +9.8%). Revenue growth, 5-year rate: +3.6%, growth has slowed since the five-year average. Earnings per share, 3-year rate: +12%, earnings outgrew revenue: margins or the share count worked for shareholders. Years of annual history on file: 18, FY2008 to FY2025, as filed.

ALGNAlign Technology

Healthcare

$142.75+7.7% 1Y

$142.75

$124.8852 weeks$197.51

Is it growing?

Mixed

Neither accelerating nor breaking down: nothing decisive, though operating margin narrowing (−2.0 points).

1 to watch, 2 neutral

Revenue trend+4% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +4% a year.

Earnings trend−3% in a year

Trailing-twelve-month earnings per share against a year earlier. Growing slower than revenue, so the growth is costing something.

Margin direction−2.0 points operating

Trailing-twelve-month operating margin, 13.2% now against 15.1% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

Revenue growth, 3 yearsmiddle of the market

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is ALGN growing?

Align Technology has grown revenue 3.5% a year over three years and 3.6% a year over five, with earnings per share compounding at 12%.

+3.5%

Revenue growth, 3-year annual rate · Medical Instruments & Supplies median +9.8% · growing slowly · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +3.6%
Revenue growth, 5-year rate · +3.5% over three · growth has slowed since the five-year average
Earnings per share, 3-year rate: +12%
Earnings per share, 3-year rate · revenue +3.5% · earnings outgrew revenue: margins or the share count worked for shareholders
Years of annual history on file: 18
Years of annual history on file · FY2008 to FY2025, as filed